Related Experiment Video
Updated: Mar 28, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Patient satisfaction after sclerotherapy of venous malformations in children
Kengo Nakahata1, Shuichiro Uehara1, Masahiro Zenitani1
1Departments of Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Insights
Percutaneous sclerotherapy effectively treated pediatric venous malformations (VMs), significantly reducing symptoms like swelling and pain. Most young patients reported satisfaction with the long-term outcomes of this safe and effective procedure.
Area of Science:
- Vascular Surgery
- Pediatric Interventional Radiology
- Dermatology
Background:
- Percutaneous sclerotherapy is used for pediatric venous malformations (VMs).
- Long-term outcome data are needed for patient and parent counseling.
- This study evaluates long-term patient satisfaction after percutaneous sclerotherapy for VMs.
Purpose of the Study:
- To retrospectively assess long-term patient satisfaction.
- To evaluate the effectiveness of percutaneous sclerotherapy for pediatric VMs.
Main Methods:
- 53 pediatric patients (<16 years) with VMs underwent sclerotherapy.
- Sclerotherapy agents included polidocanol, absolute ethanol, or ethanolamine oleate (EO).
- 50 patients received self-assessment questionnaires; 42 (84%) responded.
Main Results:
- Median follow-up was 1.8 years; median 2 sessions per patient.
- Significant symptom improvement reported: less pain (82%), functional limitation (78%), swelling (70%), and cosmetic disfigurement (59%).
- 71% of patients were satisfied or very satisfied; none reported worsening symptoms.
Conclusions:
- Percutaneous sclerotherapy is a safe and effective treatment for pediatric VMs.
- The procedure significantly alleviates symptoms and improves quality of life.
- High patient satisfaction rates support its use in pediatric venous malformations.
Background:
We have introduced and performed percutaneous sclerotherapy on pediatric patients, and information regarding the mid- and long-term results after percutaneous treatment of peripheral venous malformations is necessary to counsel patients and their parents about the outcome of the therapy. This study was designed to retrospectively evaluate the long-term satisfaction of pediatric patients following percutaneous sclerotherapy for venous malformations (VMs).
Methods:
A total of 53 children younger than 16 years of age with VMs who underwent sclerotherapy were included in this study. Self-assessment questionnaires regarding the treatment effectiveness and patients' satisfaction were sent to 50 of 53 patients. Sclerotherapy was performed using 3% polidocanol, absolute ethanol, or 5% ethanolamine oleate (EO).
Results:
The median numbers of sessions per patient was 2.0 (range, 1-12), and the median follow-up time was 1.8 years (range, 6months-8.3years). Forty-two patients (84%) returned the questionnaire. The most frequent symptom was swelling (95%, 40/42) before sclerotherapy. After treatment, patients felt less pain (82%, 23/28), functional limitation (78%, 14/18), swelling (70%, 28/40), and cosmetic disfigurement (59%, 13/22). None of the patients responded "worse" for any symptoms, and 30 patients (71%) reported being "very satisfied" or "satisfied" with the treatment.
Conclusion:
Percutaneous sclerotherapy of VMs was safe and effective for relieving symptoms in our pediatric patients, and many of them were satisfied with the outcomes.
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

